NEW YORK (GenomeWeb) – The National Cancer Institute announced that it is seeking grant applications for projects researching cancer epidemiology, genomics, and risk assessment as part of a broader effort to understand the determinants of cancer and cancer-related outcomes.
Through the funding opportunity, the NCI is aiming to address five key areas that are of high priority for its Epidemiology and Genomics Research Program, including the development and validation of methods and technologies for cancer epidemiology; the identification of modifiable risk factors or host susceptibility factors; clinical and translational epidemiology; and risk factor assessment.
The NCI is specifically seeking applications for early- and conceptual-stage research into areas that may include, but are not limited to, the evaluation of cancer risk associated with exogenous and endogenous factors; the application of epigenetic approaches in cancer epidemiology; secondary data analysis existing genome-wide data; and new biomarker technologies.
"While these studies may involve considerable risk, they may also lead to a breakthrough in a particular area and to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research," the NCI said.
The total amount of funding available will depend on National Institutes of Health appropriations and the submission of a sufficient number of meritorious applications, the agency added. However, it has set a two-year limit for each project, with total direct costs not to exceed $275,000.
Additional details about the funding opportunity can be found here.